CSF2 and neoplasm: This was coupled with an increase in GM-CSF (two-fold, P<0.01), IFN-γ (4.2-fold, P<0.01), CXCL9 (1.4-fold, P<0.01), and CXCL10 (1.7-fold, P<0.05) within the tumour microenvironment (Figure 3A and B).